Skip to content

Opening book details…

About this Medicine article

901 ADDING SIMEPREVIR (TMC435) TO PEGYLATED INTERFERON/ RIBAVIRIN DOES NOT INCREASE PATIENT REPORTED FATIGUE IN TREATMENT-EXPERIENCED PATIENTS WITH CHRONIC HCV INFECTION: RESULTS FROM THE ASPIRE TRIAL by Scott, J.; Rosa, K.; Zeuzem, S.; Beumont-Mauviel, M.; Peeters, M.; Cerri, K.; Fu, M.; Gilles, L. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Scott, J.; Rosa, K.; Zeuzem, S.; Beumont-Mauviel, M.; Peeters, M.; Cerri, K.; Fu, M.; Gilles, L.
Publisher
Elsevier Science; Elsevier ; Elsevier BV; Wiley (ISSN 0168-8278)
Published
2013
Language
EN
Field
Medicine (Health Sciences)

More by Scott, J.; Rosa, K.; Zeuzem, S.; Beumont-Mauviel, M.; Peeters, M.; Cerri, K.; Fu, M.; Gilles, L.

Browse all works by Scott, J.; Rosa, K.; Zeuzem, S.; Beumont-Mauviel, M.; Peeters, M.; Cerri, K.; Fu, M.; Gilles, L.